35.15
-2.38
(-6.34%)
At close: January 17 at 4:00:00 PM EST
34.80
-0.35
(-1.00%)
After hours: January 17 at 4:08:03 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 17 | 12 | 19 | 19 |
| Avg. Estimate | -0.24 | -0.42 | -1.72 | -1.19 |
| Low Estimate | -0.37 | -0.59 | -1.86 | -1.51 |
| High Estimate | -0.05 | -0.19 | -1.52 | -0.72 |
| Year Ago EPS | -0.27 | -0.64 | -1.57 | -1.72 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 18 | 12 | 20 | 21 |
| Avg. Estimate | 251.39M | 220.7M | 909.02M | 1.01B |
| Low Estimate | 244.8M | 213.88M | 903.3M | 984.2M |
| High Estimate | 281M | 230M | 938.6M | 1.04B |
| Year Ago Sales | 196.8M | 191.67M | 747.72M | 909.02M |
| Sales Growth (year/est) | 27.74% | 15.14% | 21.57% | 10.95% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.26 | -0.76 | -0.53 | -0.41 |
| EPS Actual | -0.27 | -0.64 | -0.48 | -0.36 |
| Difference | -0.01 | 0.12 | 0.05 | 0.05 |
| Surprise % | -4.54% | 16.27% | 10.05% | 12.20% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.24 | -0.42 | -1.72 | -1.19 |
| 7 Days Ago | -0.24 | -0.43 | -1.72 | -1.19 |
| 30 Days Ago | -0.24 | -0.43 | -1.72 | -1.2 |
| 60 Days Ago | -0.24 | -0.44 | -1.72 | -1.2 |
| 90 Days Ago | -0.21 | -0.42 | -1.73 | -1.2 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 3 | 6 | -- |
| Up Last 30 Days | 2 | 3 | 6 | 1 |
| Down Last 7 Days | 9 | 2 | 3 | 1 |
| Down Last 30 Days | 9 | 2 | 3 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| TNDM | 11.79% | 33.46% | -9.38% | 30.57% |
| S&P 500 | 9.47% | 11.36% | 13.97% | 13.61% |
Upgrades & Downgrades
| Maintains | Citigroup: Buy to Buy | 12/11/2024 |
| Upgrade | Morgan Stanley: Equal-Weight to Overweight | 12/2/2024 |
| Maintains | Barclays: Overweight to Overweight | 11/8/2024 |
| Maintains | Canaccord Genuity: Buy to Buy | 11/7/2024 |
| Maintains | Baird: Neutral to Neutral | 11/7/2024 |
| Initiated | Bernstein: Outperform | 11/6/2024 |
Related Tickers
PODD Insulet Corporation
275.81
+1.08%
DXCM DexCom, Inc.
84.38
-0.54%
QDEL QuidelOrtho Corporation
41.74
-0.33%
GKOS Glaukos Corporation
156.39
-0.08%
IRTC iRhythm Technologies, Inc.
108.33
+1.25%
BRKR Bruker Corporation
56.88
-3.61%
INSP Inspire Medical Systems, Inc.
177.68
+2.21%
PEN Penumbra, Inc.
263.69
+0.53%
NARI Inari Medical, Inc.
79.55
+0.19%
PRCT PROCEPT BioRobotics Corporation
76.02
-3.58%